ACA WEBINAR: MEN AND COVID SEVERITY – New Research that Links Them … What Are the Implications?
Earn 1.0 hour (0.1 CEUs) of continuing education credit when you purchase the webinar, MEN AND COVID SEVERITY – New Research that Links Them … What Are the Implications?
This activity explores recent research highlighting the hormonal differences that may contribute to why men experienced more severe outcomes from COVID-19 compared to women. Participants will examine the role of testosterone in immune response and how its levels—and conversion to other hormones like estradiol—may have influenced COVID-19 severity in male patients. The session will also address how this hormonal imbalance might relate to other acute viral illnesses beyond COVID-19, offering broader clinical insight.
In addition, the activity will cover current evidence on testosterone therapy and its impact on cardiovascular health and prostate cancer risk, including discussion of ongoing large-scale studies such as the TRAVERSE trial. Participants will review the physiological role of dihydrotestosterone (DHT), testosterone’s more potent metabolite, and how understanding these hormonal mechanisms can help guide discussions around men’s health.
By the end of the activity, pharmacists and pharmacy technicians will be better equipped to evaluate emerging literature, understand the implications of hormone-related research, and communicate effectively with both patients and healthcare providers. This knowledge will enhance their ability to engage in meaningful conversations about hormone therapy, risks and benefits, and personalized care approaches related to testosterone and viral disease outcomes.
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 1 contact hour (0.1 CEUs) of continuing education credit for pharmacists and pharmacy technicians.